<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>Zibb.com: Bio-Imaging Technologies, Incorporated (Industry News &amp; Blogs)</title><link>http://www.zibb.com/all/theme/cq/Bio-Imaging+Technologies,+Incorporated</link><atom:link rel="self" type="application/rss+xml" href="http://www.zibb.com/all/theme/cq/Bio-Imaging+Technologies,+Incorporated" /><description>
					Zibb. The Global business search engine.
				</description><language>
					en-US
				</language><webMaster>search@zibb.com (RB Search)</webMaster><copyright>Copyright (c) 2007 Reed Business Information. All rights reserved.</copyright><pubDate>Mon, 01 Jun 2009 12:00:00 GMT</pubDate><lastBuildDate>Mon, 01 Jun 2009 12:00:00 GMT</lastBuildDate><ttl>60</ttl><image><title>Zibb.com: Bio-Imaging Technologies, Incorporated (Industry News &amp; Blogs)
          </title><width>88</width><height>31</height><link>http://www.zibb.com/all/theme/cq/Bio-Imaging+Technologies,+Incorporated</link><url>
						http://www.zibb.com/images/en/g_zibb_logo_beta.gif
					</url></image><item><title>Bio-Imaging Technologies, Inc. and etrials Merger Agreement Termi...
      </title><link>http://www.biospace.com/news_story.aspx?StoryID=142993&amp;full=1</link><description>NEWTOWN, Pa.--(BUSINESS WIRE)--Bio-Imaging Technologies, Inc. (NASDAQ: BITI - News) (d/b/a "BioClinica”) announces that, in response to another unsolicited offer received by etrials Worldwide, Inc.</description><guid>http://www.biospace.com/news_story.aspx?StoryID=142993&amp;full=1</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Mon, 01 Jun 2009 12:00:00 GMT</pubDate><source url="http://www.biospace.com" /></item><item><title>Bio-Imaging Technologies makes tender offer for etrials Worldwide</title><link>http://www.bizjournals.com/philadelphia/stories/2009/05/04/daily16.html?ana=from_rss</link><description>Under the proposed offer, etrials (NASDAQ:ETWC) stockholders will receive 0.124 shares of newly issued Bio-Imaging (NASDAQ:BITI) common stock and 15 cents per etrials share. The offer represents a 27 premium to the average closing price for etrials stock for the past 30 days.</description><guid>http://www.bizjournals.com/philadelphia/stories/2009/05/04/daily16.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Tue, 05 May 2009 14:17:19 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Amgen: Remember Its Biotech Bloodlines?</title><link>http://seekingalpha.com/article/104972-amgen-remember-its-biotech-bloodlines?source=feed</link><description>Ryan Barnes submits:Amgen (AMGN) is one of the founding fathers of biopharma, but after showing its age in recent years with slowing</description><guid>http://seekingalpha.com/article/104972-amgen-remember-its-biotech-bloodlines?source=feed</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Sun, 09 Nov 2008 14:32:36 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Bio Imaging Technologies "buy," target price raised</title><link>http://www.newratings.com/main/company_headline.m?section=company&amp;option=headline&amp;id=1719473</link><description>NEW YORK, March 26 (newratings.com) - Analysts at Roth Capital reiterate their "buy" rating on Bio Imaging Technologies Inc (ticker: BITI). The target price has been raised from $10 to $11. [&lt;a</description><guid>http://www.newratings.com/main/company_headline.m?section=company&amp;option=headline&amp;id=1719473</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Wed, 26 Mar 2008 14:56:50 GMT</pubDate><source url="http://www.newratings.com" /></item><item><title>Bio-Imaging Technologies Partners with AG Mednet to Offer Complet...
      </title><link>http://www.prweb.com/releases/ag_mednet/imaging_technologies/prweb1721264.htm</link><description>PR: Bio-Imaging Technologies, Inc. (NASDAQ:BITI), a healthcare contract service organization that supports product development for the pharmaceutical, biotechnology and medical device industries, today announced it has partnered with AG Mednet, a global diagnostic imaging network, to provide a</description><guid>http://www.prweb.com/releases/ag_mednet/imaging_technologies/prweb1721264.htm</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Thu, 01 Jan 1970 00:00:00 GMT</pubDate><source url="http://www.prweb.com" /></item><item><title>Bio-Imaging Technologies Inc. News - The New York Times</title><link>http://topics.nytimes.com/top/news/business/companies/bio-imaging-technologies-inc/index.html</link><description>Get Home Delivery Log In Register Now Home Page My Times Today's Paper Video Most Popular Times Topics Business All NYT New York Times Business World U.S. N.Y. / Region Business Media &amp; Advertising World Business Small Business Your Money DealBook Markets Research Mutual Funds My Portfolio Alerts</description><guid>http://topics.nytimes.com/top/news/business/companies/bio-imaging-technologies-inc/index.html</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate /><source url="http://topics.nytimes.com" /></item><item><title>Bio-Imaging Technologies, Inc., Incorporated</title><link>http://www.icongrouponline.com/pr/Bio-Imaging_Technologies,_Inc_US/PR.html</link><description>San Diego -- – Released today by ICON Group International Ltd.: Two of the most comprehensive studies to date on vertical gap analysis and labor productivity benchmarks for Bio-Imaging Technologies, Inc. (OTC: BITI).</description><guid>http://www.icongrouponline.com/pr/Bio-Imaging_Technologies,_Inc_US/PR.html</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate /><source url="http://www.icongrouponline.com" /></item><item><title>PharmaLive: Bio-Imaging Technologies Partners with AG Mednet to O...
      </title><link>http://www.pharmalive.com/News/index.cfm?articleid=590739&amp;categoryid=20</link><description>The new service enables fast delivery of clinical trial images through a web accessible, secure network between clinical sites and Bio-Imaging's Imaging Core Lab (ICL), increasing efficiency while reducing costs.</description><guid>http://www.pharmalive.com/News/index.cfm?articleid=590739&amp;categoryid=20</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate /><source url="http://www.pharmalive.com" /></item><item><title>Genentech investments sour with market crash</title><link>http://www.bizjournals.com/sanfrancisco/stories/2008/10/27/story9.html?ana=from_rss</link><description>The South San Francisco company took a $67 million third-quarter charge for impaired investments, primarily tied to preferred stock in Fannie Mae, Freddie Mac and Lehman Brothers Holdings Inc.</description><guid>http://www.bizjournals.com/sanfrancisco/stories/2008/10/27/story9.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Mon, 27 Oct 2008 04:00:00 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Rising need for transfusions may help Cerus’ blood cleaners</title><link>http://www.bizjournals.com/eastbay/stories/2008/09/15/story8.html?ana=from_rss</link><description>A recent FDA decision and changing surgical needs are increasing demand for blood transfusions – potentially boosting the long-term prospects for Cerus Corp., which makes blood safety systems.</description><guid>http://www.bizjournals.com/eastbay/stories/2008/09/15/story8.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Mon, 15 Sep 2008 04:00:00 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>As dollar strengthens, Genentech offer sits</title><link>http://www.bizjournals.com/sanfrancisco/stories/2008/09/15/story10.html?ana=from_rss</link><description>A rising dollar and a rejection of its initial offer won’t push Roche Holding to table its all-out acquisition of Genentech Inc., biotech watchers say.</description><guid>http://www.bizjournals.com/sanfrancisco/stories/2008/09/15/story10.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Mon, 15 Sep 2008 04:00:00 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Roche's tough balancing act: Making everyone happy</title><link>http://www.bizjournals.com/sanfrancisco/stories/2008/07/28/newscolumn4.html?ana=from_rss</link><description>The question becomes: How will Roche make everyone happy, happy, happy -- as in happy employees, happy shareholders and happy Bay Area biotech community? For all purposes, Genentech and Roche already are merged. Roche owns about 55.</description><guid>http://www.bizjournals.com/sanfrancisco/stories/2008/07/28/newscolumn4.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Mon, 28 Jul 2008 04:00:00 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Genentech forms committee to look at Roche offer - Bizjournals.co...
      </title><link>http://www.bizjournals.com/sanfrancisco/stories/2008/07/21/daily78.html</link><description>The chairman of a special Genentech Inc. board committee looking at Roche Holding's $44 billion offer to buy the remainder of the South San Francisco biotech company sounded a cautionary tone Thursday.</description><guid>http://www.bizjournals.com/sanfrancisco/stories/2008/07/21/daily78.html</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Thu, 24 Jul 2008 23:27:33 GMT</pubDate><source url="http://www.bizjournals.com" /></item><item><title>Bio Imaging Technologies "buy," target price reduced</title><link>http://www.newratings.com/main/company_headline.m?section=company&amp;option=headline&amp;id=1719444</link><description>NEW YORK, March 26 (newratings.com) - Analysts at Broadpoint Capital reiterate their "buy" rating on Bio Imaging Technologies Inc (ticker: BITI). The target price has been reduced from $12 to $11. [&lt;a</description><guid>http://www.newratings.com/main/company_headline.m?section=company&amp;option=headline&amp;id=1719444</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Wed, 26 Mar 2008 14:32:05 GMT</pubDate><source url="http://www.newratings.com" /></item><item><title>Bio-Imaging Technologies: Picture Perfect</title><link>http://seekingalpha.com/article/59809-bio-imaging-technologies-picture-perfect?source=feed</link><description>When it comes to the medical imaging services required to complete pharmaceutical clinical research, Bio-Imaging Technologies, Inc. (Nasdaq: BITI) has an unbeatable image.&lt;a</description><guid>http://seekingalpha.com/article/59809-bio-imaging-technologies-picture-perfect?source=feed</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Fri, 11 Jan 2008 09:01:40 GMT</pubDate><source url="http://seekingalpha.com" /></item><item><title>Brooke names Baranowski as CEO, details turnover of board</title><link>http://www.bizjournals.com/kansascity/stories/2008/10/20/daily9.html?ana=from_rss</link><description>Carl Baranowski has been named as president, CEO and secretary of Brooke Corp. after a housecleaning that has left the company with a board of directors consisting of one person. Baranowski has served as general counsel for the company.</description><guid>http://www.bizjournals.com/kansascity/stories/2008/10/20/daily9.html?ana=from_rss</guid><category domain="http://www.zibb.com">Bio-Imaging Technologies, Incorporated</category><pubDate>Tue, 21 Oct 2008 16:51:41 GMT</pubDate><source url="http://www.bizjournals.com" /></item></channel></rss>